Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. (AMPE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ampe · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Ampio Pharmaceuticals, Inc. (AMPE) measures how much investors pay for each dollar of the company's trailing earnings. AMPE's current PE ratio of N/A is calculated by dividing its stock price of $0.18 by its TTM earnings per share of -$10.67.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2006 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Ampio Pharmaceuticals, Inc.You AMPE | $0M | N/A | — | -$10.67 |
 Arno Therapeutics, Inc. ARNI | $0M | N/A | — | -$0.57 |
 Better Therapeutics, Inc. BTTX | $0M | N/A | — | -$1.69 |
 Baudax Bio, Inc. BXRXQ | $0M | N/A | — | -$177.30 |
 Calithera Biosciences, Inc. CALA | $0M | N/A | — | -$3.78 |
 Innovation1 Biotech Inc. IVBT | $0M | N/A | — | -$0.30 |
 Kaleido Biosciences, Inc. KLDO | $0M | N/A | — | -$2.16 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | — | $-10.67 | — | |
2022-12-31 FY2022 | — | $-29.33 | — | |
2021-12-31 FY2021 | — | $-25.70 | — | |
2020-12-31 FY2020 | — | $-27.59 | — | |
2019-12-31 FY2019 | — | $-28.75 | — | |
2018-12-31 FY2018 | 0.84x | $138.99 | — | |
2017-12-31 FY2017 | — | $-239.13 | — | |
2016-12-31 FY2016 | — | $-107.06 | — | |
2015-12-31 FY2015 | — | $-184.70 | — | |
2014-12-31 FY2014 | — | $-227.72 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Ampio Pharmaceuticals, Inc. (AMPE) measures how much investors pay for each dollar of the company's trailing earnings. AMPE's current PE ratio of N/A is calculated by dividing its stock price of $0.18 by its TTM earnings per share of -$10.67.
Frequently asked questions
AMPE pe ratio · 6 questionsAMPE's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.18 and TTM EPS of -$10.67. Data sourced from Financial Modeling Prep via AMPE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Ampio Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08